2015
DOI: 10.1016/j.suronc.2015.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
35
0
7

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(43 citation statements)
references
References 19 publications
1
35
0
7
Order By: Relevance
“…Of 567 studies identified from the initial search, 35 cohort studies (4244 subjects) satisfied the inclusion and exclusion criteria, and were included in this meta‐analysis (Fig . , Table ).…”
Section: Resultsmentioning
confidence: 99%
“…Of 567 studies identified from the initial search, 35 cohort studies (4244 subjects) satisfied the inclusion and exclusion criteria, and were included in this meta‐analysis (Fig . , Table ).…”
Section: Resultsmentioning
confidence: 99%
“…The greatest advantage of the ICG fluorescence imaging system is that it allows visualization of SN and afferent lymphatic vessels from primary tumor sites more clearly than a conventional dye approach based on visual recognition without special tools. To date, several investigators have demonstrated the clinical benefit of the ICG fluorescence imaging approach for SN detection in patients with several malignancies, including gastric cancer 16, 17, 18, 19…”
Section: A Novel Imaging System Developed For Sn Detectionmentioning
confidence: 99%
“…Some investigators analyzed the false-negative rate of ICG in SLNB and found it to be lower than 10 % [22,24,[26][27][28][30][31][32][33]. A meta-analysis of six studies, which used ICG as a tracer in SLNB of breast cancer patients, reported the sensitivity of about 92 % (85 %-96 %) and the specificity of about 100 % (97 %-100 %) [34].…”
Section: The Developing Stagementioning
confidence: 99%